“…I. Campbell, Weisner, & Sterling, 2006; Satre, Campbell, Gordon, & Weisner, 2010), which may be a result of heightened stigma around mental health and substance use problems and treatment in some communities (Alegria, Carson, Goncalves, & Keefe, 2011; Gary, 2005; Knifton et al, 2010; Mulvaney-Day, DeAngelo, Chen, Cook, & Alegria, 2012; Rose, Joe, & Lindsey, 2011). Providers or health systems adopting SBIRT should consider whether non-white patients need additional support and encouragement to access needed specialty treatment (Manuel et al, 2015), and whether access to a BHC trained in substance use and mental health problems based in pediatric primary care may better meet their needs and preferences. Specialty treatment programs may need to assess whether current programming, treatment approaches and staffing are equipped to appeal to and meet the linguistic and cultural needs of increasingly diverse patient populations, and may need to do more outreach to these patient populations (Alegria, Alvarez, Ishikawa, DiMarzio, & McPeck, 2016).…”